Indraprastha Apollo Hospitals in New Delhi marked a significant milestone in cardiac care by hosting a press conference today, showcasing the pioneering work of renowned cardiac surgeons Dr. MM Yusuf and Dr. Varun Bansal. The event highlighted the hospital’s advanced adoption of robotic heart surgery and robotic coronary artery bypass grafting (CABG), emphasizing the remarkable success rates and patient benefits these technologies offer.
Indraprastha Apollo Hospitals has set a benchmark in robotic cardiac surgery with a 98% success rate and minimal associated risks. Robotic heart surgery represents a minimally invasive approach that leverages advanced robotic technology and surgical precision, allowing procedures to be performed through small incisions. Compared to traditional open-heart surgery, robotic techniques offer numerous advantages, including the use of all arterial grafts, reduced complications, no bone cutting, significantly shorter recovery times, and minimal scarring.
The conference underscored how these advanced surgical methods translate into immediate and long-term benefits for patients across all age groups. The minimally invasive nature of robotic surgery allows patients to begin walking within a day of surgery and often leads to discharge within 48-72 hours. These procedures are crucial for treating conditions such as coronary artery disease, heart valve diseases, heart tumors, and congenital heart defects.
Dr. MM Yusuf, Senior Consultant, Heart Specialist in Robotics and Minimally Invasive Heart Surgery at Indraprastha Apollo Hospitals, expressed the transformative impact of robotic cardiac surgery on patient care. “Robotic cardiac surgery signifies a transformative advancement in heart care. By leveraging cutting-edge robotic technology, we can perform highly precise and minimally invasive procedures that significantly reduce recovery times and postoperative complications. Our patients benefit from quicker mobilization, reduced scarring, and a faster return to normal life, typically within 2-3 weeks. This is particularly beneficial for younger patients who can rejoin work quickly and for older patients who can avoid complications. This innovative approach is revolutionizing cardiac surgery, and we are proud to be at the forefront, providing exceptional care to our patients.”
Echoing these sentiments, Dr. Varun Bansal, Consultant Heart Specialist in Robotics and Minimally Invasive Heart Surgery, emphasized the holistic benefits of robotic surgeries. “Robotic and minimally invasive cardiac surgeries represent a significant leap forward in cardiac care. By integrating advanced technology with surgical expertise, we offer our patients fewer complications, faster recoveries, and a better overall quality of life. This approach enhances the precision and safety of procedures while significantly reducing the physical, emotional, and financial burden on patients and their families. Many of our patients can start walking within a day of surgery and are often discharged within 48-72 hours, highlighting the effectiveness and patient satisfaction with these techniques. We are witnessing an increasing number of patients from diverse age groups and backgrounds opting for these advanced surgical options. We firmly believe that robotic cardiac surgery will continue to evolve, setting new standards in heart surgery and providing the best possible care for our patients.”
The growing demand for robotic surgery is evident, with the global market projected to reach $25.4 billion USD by 2030, up from $8 billion USD today. In India, the minimally invasive approach is gaining significant traction, with an estimated 20 robotic cardiac surgeries performed daily. Indraprastha Apollo Hospitals is proud to be a key contributor to this advancement, reflecting its commitment to innovative healthcare solutions.
During the conference, Dr. Yusuf and Dr. Bansal presented detailed case studies showcasing the hospital’s expertise in managing complex conditions with robotic assistance. They shared patient stories, including those who were high-risk for open-heart surgery, individuals seeking a quick return to work and active life, and those preferring minimal scarring. These patients recovered swiftly and resumed their lives quickly, underscoring the effectiveness of robotic cardiac surgeries.
Indraprastha Apollo Hospitals remains at the forefront of cardiac care, continually leveraging advanced robotic technologies to improve patient outcomes. As the field of robotic cardiac surgery continues to grow, the hospital is dedicated to setting new standards and ensuring the highest quality of care for its patients.
About Indraprastha Apollo Hospitals:
Indraprastha Apollo Hospitals, India’s first JCI-accredited hospital, is a joint venture between the Government of Delhi and Apollo Hospitals Enterprise Limited. Commissioned in July 1996, it is the third super-specialty tertiary care hospital established by the Apollo Hospitals Group. Spanning 15 acres, the hospital offers 57 specialties, more than 300 specialists, over 700 operational beds, 19 operation theatres, 138 ICU beds, a round-the-clock pharmacy, NABL-accredited laboratories, 24-hour emergency services, and an active air ambulance service. Indraprastha Apollo has the leading program in kidney and liver transplants in the country, including the first successful pediatric and adult liver transplants in India.
The hospital is at the forefront of medical technology and expertise, offering a comprehensive range of the latest diagnostic, medical, and surgical facilities for patient care. The hospital has consistently been ranked among the top 10 hospitals in India by The Week survey in recent years.
